Abvc Biopharma (ABVC) Accumulated Expenses (2010 - 2023)
Abvc Biopharma's Accumulated Expenses came in at $3.7 million for Q4 2023, up 27.0% from $2.91 million a year earlier and up 3.9% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Accumulated Expenses (2010 - 2023) Analysis & Trends
Going back to Q4 2010, Abvc Biopharma's Accumulated Expenses data covers 35 quarters.
- Accumulated Expenses carries a five-year compound annual growth rate of 24.4% (FY2018 to FY2023).
- Going back by year, Accumulated Expenses was $2.91 million in FY2022 (+123.7%), $1.3 million in FY2021 (-38.6%), $2.12 million in FY2020 (+5.5%) and $2.01 million in FY2019 (+61.5%).
- The Q4 2023 figure represents the highest quarterly Accumulated Expenses in data going back to Q4 2010.
- Year-over-year, Accumulated Expenses has increased for six consecutive quarters, with growth averaging 71.9% over the last eight quarters.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q1 2019 (growth of 669.0%), and the weakest in Q3 2021 (a decline of 58.5%).
- Business Quant data shows ABVC's Accumulated Expenses at $3.56 million (Q3 2023), $3.44 million (Q2 2023) and $2.76 million (Q1 2023) in the three quarters before Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 3.70 Mn |
| Sep 30, 2023 | 3.56 Mn |
| Jun 30, 2023 | 3.44 Mn |
| Mar 31, 2023 | 2.76 Mn |
| Dec 31, 2022 | 2.91 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Mar 31, 2022 | 1.25 Mn |
| Dec 31, 2021 | 1.30 Mn |
| Sep 30, 2021 | 1.13 Mn |
| Jun 30, 2021 | 1.87 Mn |
| Mar 31, 2021 | 2.14 Mn |
| Dec 31, 2020 | 2.12 Mn |
| Sep 30, 2020 | 2.73 Mn |
| Jun 30, 2020 | 2.91 Mn |
| Dec 31, 2019 | 2.01 Mn |
| Sep 30, 2019 | 1.76 Mn |
| Jun 30, 2019 | 1.70 Mn |
| Mar 31, 2019 | 1.56 Mn |
| Dec 31, 2018 | 1.24 Mn |
API Access
Abvc Biopharma Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();